Article Text
Statistics from Altmetric.com
A clinicopathological conference (CPC) perhaps exemplifies both what non-neurologists consider neurology to be, and what many neurologists consider to be the pinnacle of their art. A brave discussant is confronted by an invariably obscure and more often than not untreatable case which they are tasked with dissecting in full sight of their peers, armed only with his/her clinical acumen. While ostensibly the aim is to predict the correct diagnosis, equally if not more important is to take the audience on an entertaining journey, explaining the diagnostic thought processes en route. In the CPC reported in this edition of Practical Neurology, Rhys Davies admirably rises to this challenge, elegantly taking us through his reasoning, discarding a few red herrings along the way, before finally and correctly predicting the underlying diagnosis of Nasu-Hakola disease, a very rare genetic form of dementia associated with bone cysts.1
Cases presented in CPCs are of course poles apart from those encountered in routine neurological practice which is, quite rightly, …
Footnotes
Twitter @jmschott
Contributors JMS is the sole author of this paper.
Funding The author acknowledges the support of the UCL/H NIHR Biomedical Research Centre
Competing interests JMS is Chief Medical Officer for Alzheimer's Research UK and Clinical Advisor to the UK Dementia Research Institute.
Provenance and peer review Commissioned; externally peer reviewed by Huw Morris, London, UK.
Linked Articles
- Clinicopathological conference
Read the full text or download the PDF:
Other content recommended for you
- A rare cause of young-onset dementia
- Convergent molecular defects underpin diverse neurodegenerative diseases
- Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum
- Frontotemporal dementia presentation in patients with heterozygous p.H157Y variant of TREM2
- Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease
- Cerebellar atrophy in neurodegeneration—a meta-analysis
- Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
- Neurofilament light chain as a biomarker in neurological disorders
- 31st Advanced Clinical Neurology Course, Edinburgh 2009: progressive cognitive impairment, behavioural change and upper motor neuron signs in a 57-year-old woman
- Fluid biomarkers in frontotemporal dementia: past, present and future